Idexx Laboratories vs Neogen: revenue, profit, margins and growth compared
Idexx Laboratories brought in $4.3B of revenue in fiscal 2025, Neogen $870.4M in fiscal 2026. Revenue changed by +10.4% at Idexx Laboratories and -2.7% at Neogen on the year before, so Idexx Laboratories grew faster. Idexx Laboratories kept 24.6% of its revenue as net profit, Neogen -0.9%. Free cash flow was $1.1B at Idexx Laboratories and $31.9M at Neogen.
Fiscal years as each company reports them; the two may end in different months.
Questions about Idexx Laboratories and Neogen
Which is bigger by revenue, Idexx Laboratories or Neogen?
Idexx Laboratories is bigger by revenue: $4.3B in fiscal 2025, against $870.4M for Neogen in fiscal 2026.
Which keeps more of its revenue as profit, Idexx Laboratories or Neogen?
Idexx Laboratories had a net margin of 24.6% in fiscal 2025; Neogen had -0.9% in fiscal 2026.
Which grew revenue faster, Idexx Laboratories or Neogen?
In their latest fiscal years revenue changed by +10.4% at Idexx Laboratories and -2.7% at Neogen.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.